{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T22:08:23Z","timestamp":1740175703409,"version":"3.37.3"},"reference-count":11,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,25]],"date-time":"2016-03-25T00:00:00Z","timestamp":1458864000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cirug\u00eda y Cirujanos"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.circir.2016.03.011","type":"journal-article","created":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T04:26:22Z","timestamp":1462076782000},"page":"260-263","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Devastadora complicaci\u00f3n tras tratamiento con aflibercept"],"prefix":"10.1016","volume":"85","author":[{"given":"Est\u00edbaliz","family":"Echazarreta-Gallego","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela","family":"El\u00eda-Guedea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"C\u00f3rdoba-D\u00edaz de Laspra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.circir.2016.03.011_bib0060","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/caac.21254","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"Ca Cancer J Clin."},{"issue":"44","key":"10.1016\/j.circir.2016.03.011_bib0065","doi-asserted-by":"crossref","first-page":"7955","DOI":"10.3748\/wjg.v19.i44.7955","article-title":"Anti-angiogenic therapies for metastatic colorectal cancer: Current and future perspectives","volume":"19","author":"Marques","year":"2013","journal-title":"World J Gastroenterol."},{"issue":"19","key":"10.1016\/j.circir.2016.03.011_bib0070","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1093\/jnci\/djh275","article-title":"Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging","volume":"96","author":"O\u2019Connell","year":"2004","journal-title":"Natl Cancer Inst."},{"issue":"9","key":"10.1016\/j.circir.2016.03.011_bib0075","doi-asserted-by":"crossref","first-page":"9419","DOI":"10.1007\/s13277-014-2189-1","article-title":"Hemorrhagic events in cancer patients treated with aflibercept: A meta-analysis","volume":"35","author":"Peng","year":"2014","journal-title":"Tumour Biol."},{"issue":"2","key":"10.1016\/j.circir.2016.03.011_bib0080","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s11912-013-0368-7","article-title":"Aflibercept: A decoy VEGF receptor","volume":"16","author":"Ciombor","year":"2014","journal-title":"Curr Oncol Rep."},{"issue":"4","key":"10.1016\/j.circir.2016.03.011_bib0085","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00228-013-1633-2","article-title":"Treatment-related mortality with aflibercept in cancer patients: A meta-analysis","volume":"70","author":"Qi","year":"2014","journal-title":"Eur J Clin Pharmacol."},{"issue":"11","key":"10.1016\/j.circir.2016.03.011_bib0090","doi-asserted-by":"crossref","first-page":"10715","DOI":"10.1007\/s13277-014-2369-z","article-title":"Risk of gastrointestinal perforation in cancer patients treated with aflibercept: A systematic review and meta-analysis","volume":"35","author":"Qi","year":"2014","journal-title":"Tumour Biol."},{"issue":"1","key":"10.1016\/j.circir.2016.03.011_bib0095","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/bcp.12758","article-title":"Incidence and risk of severe infections associated with aflibercept in cancer patients: A systematic review and meta-analysis","volume":"81","author":"Zhang","year":"2016","journal-title":"Br J Clin Pharmacol."},{"issue":"1","key":"10.1016\/j.circir.2016.03.011_bib0100","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijrobp.2013.05.012","article-title":"Increased bowel toxicity in patients treated with a vascular endothelial growth factor inhibitor (VEGFI) after stereotactic body radiation therapy (SBRT)","volume":"87","author":"Barney","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"10.1016\/j.circir.2016.03.011_bib0105","unstructured":"Aflibercept (ziv-aflibercept) (systemic): Drug information. Lexicomp. Lexicomp, Inc. Uptodate 2015 [consultado 29 Oct 2015]. Disponible en: www.uptodate.com."},{"issue":"3","key":"10.1016\/j.circir.2016.03.011_bib0110","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.critrevonc.2013.10.002","article-title":"Risk of gastrointestinal perforation in cancer patients treated with vascular endothelial growth factor receptor tyrosine kinase inhibitors: A systematic review and meta-analysis","volume":"89","author":"Qi","year":"2014","journal-title":"Crit Rev Oncol Hematol."}],"container-title":["Cirug\u00eda y Cirujanos"],"original-title":[],"language":"es","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0009741116300238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0009741116300238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T15:50:15Z","timestamp":1539877815000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009741116300238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":11,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0009741116300238"],"URL":"https:\/\/doi.org\/10.1016\/j.circir.2016.03.011","relation":{},"ISSN":["0009-7411"],"issn-type":[{"type":"print","value":"0009-7411"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Devastadora complicaci\u00f3n tras tratamiento con aflibercept","name":"articletitle","label":"Article Title"},{"value":"Cirug\u00eda y Cirujanos","name":"journaltitle","label":"Journal Title"},{"value":"http:\/\/dx.doi.org\/10.1016\/j.circir.2016.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Academia Mexicana de Cirug\u00eda A.C. Published by Masson Doyma M\u00e9xico S.A.","name":"copyright","label":"Copyright"}]}}